The introduction of nicotinamide for a nicotine substitute in e-cigarette and smokeless products and solutions signifies an important regulatory obstacle for your FDA. Nicotinamide doesn't have nicotinic receptor agonist action and is known to work as a sedative at large dosages6. The promises p